Themis Medicare informs about quarterly statement of investor complaints

16 Jul 2016 Evaluate

Themis Medicare has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Themis Medicare Share Price

99.60 -2.10 (-2.06%)
29-Dec-2025 15:24 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.70
Dr. Reddys Lab 1268.45
Cipla 1493.20
Zydus Lifesciences 904.00
Lupin 2079.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×